Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.

Tomi JunUmut OzbekSirish DharmapuriCamille Hardy-AbeloosHuili ZhuJung-Yi LinNicola PersoneniTiziana PressianiNaoshi NishidaPei-Chang LeeChieh-Ju LeeHannah HildebrandNeil NimkarSonal PaulPetros FessasMuntaha NaeemDominik BettingerUqba KhanAnwaar SaeedYi-Hsiang HuangMasatoshi KudoLorenza RimassaThomas U MarronDavid J PinatoCelina Ang

Published in: Therapeutic advances in medical oncology (2021)

Our results suggest that exposure to PPI/H2RA prior to ICIs does not adversely affect outcomes in HCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
small molecule
patient reported outcomes
patient reported
protein protein
skeletal muscle
interstitial lung disease